This company recently went public with an IPO on Friday, May 8th 2026. They issued 15,500,000 shares at $16.00 - $18.00 per share. We will continue to update data for ODTX as it becomes available. NASDAQ:ODTX Odyssey Therapeutics (ODTX) Stock Price, News & Analysis $17.62 +0.30 (+1.73%) As of 05/15/2026 04:00 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartInsider TradesSEC FilingsTrendsBuy This Stock About Odyssey Therapeutics Stock (NASDAQ:ODTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Odyssey Therapeutics alerts:Sign Up Key Stats Today's Range$17.00▼$17.8650-Day Range N/A52-Week Range$15.35▼$20.30Volume405,143 shsAverage Volume335,229 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Read More Receive ODTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Odyssey Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ODTX Stock News HeadlinesA Boston biotech tried to go public last year but pulled back. Now it’s valued at nearly $1BMay 16 at 9:22 AM | finance.yahoo.comOdyssey Therapeutics (NASDAQ:ODTX) Upgraded at Wall Street ZenMay 16 at 1:18 AM | americanbankingnews.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. | Banyan Hill Publishing (Ad)Tpg Gp A, Llc Purchases 1,388,889 Shares of Odyssey Therapeutics (NASDAQ:ODTX) StockMay 15 at 4:43 AM | americanbankingnews.comInsider Buying: Odyssey Therapeutics (NASDAQ:ODTX) Major Shareholder Buys 1,388,889 Shares of StockMay 14 at 7:13 AM | insidertrades.comDimension Capital Ii, L.P. Buys 1,111,111 Shares of Odyssey Therapeutics (NASDAQ:ODTX) StockMay 14 at 4:13 AM | americanbankingnews.comInsider Buying: Odyssey Therapeutics (NASDAQ:ODTX) Director Buys $19,999,998.00 in StockMay 13, 2026 | insidertrades.comInsider Buying: Odyssey Therapeutics (NASDAQ:ODTX) CFO Acquires 1,000 Shares of StockMay 12, 2026 | insidertrades.comSee More Headlines ODTX Stock Analysis - Frequently Asked Questions How have ODTX shares performed this year? Odyssey Therapeutics' stock was trading at $17.45 at the start of the year. Since then, ODTX shares have increased by 1.0% and is now trading at $17.62. When did Odyssey Therapeutics IPO? Odyssey Therapeutics (ODTX) raised $264 million in an initial public offering on Friday, May 8th 2026. The company issued 15,500,000 shares at a price of $16.00-$18.00 per share. When does Odyssey Therapeutics' quiet period expire? Odyssey Therapeutics's quiet period expires on Wednesday, June 17th. Odyssey Therapeutics had issued 15,500,000 shares in its public offering on May 8th. The total size of the offering was $279,000,000 based on an initial share price of $18.00. During Odyssey Therapeutics' quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company. How do I buy shares of Odyssey Therapeutics? Shares of ODTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ODTX CIK1882782 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$2.98 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:ODTX) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX Goes Public. Here's What Happens To Your IRA.When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Odyssey Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Odyssey Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.